Medical Research Highlights — November 17, 2026
Summary for November 17, 2026. gene_therapy : institution Current Sentiment: Cautious or mixed sentiment with some intensity Harvard’s new lentiviral vector platform for sickle cell disease enters expanded access programs, with neutral coverage focusing on manufacturing scale-up challenges at Boston facilities. Alternative view: Early access has already improved quality of life metrics for 50 patients